Turn Therapeutics
TTRX
22 hedge funds and large institutions have $1.84M invested in Turn Therapeutics in 2025 Q4 according to their latest regulatory filings, with 22 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
1.58% more ownership
Funds ownership: 0% → 1.58% (+1.6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$399K |
| 2 |
WSC
Wellington Shields & Co
New York
|
+$274K |
| 3 |
DI
DDFG Inc
Thousand Oaks,
California
|
+$218K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$126K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$105K |
Top Sellers
TTRX Hedge Fund Activity: Q4 2025 in Review
22 of the 8,270 institutional investors tracked by Wall St. Rank reported a position in Turn Therapeutics (TTRX) for Q4 2025, worth a combined $1.84M.
Buyers outnumbered sellers: 22 funds opened new TTRX positions and 0 closed out — a net gain of 22 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $399K.
- 22 institutional investors held Turn Therapeutics (TTRX) as of Q4 2025, up from 0 in Q3 2025.
- Funds reported $1.84M of Turn Therapeutics stock for Q4 2025.
- 22 funds opened new Turn Therapeutics positions in Q4 2025 and 0 closed out, a net change of +22 holders.
- The largest Turn Therapeutics buyer in Q4 2025 was Millennium Management, an estimated $399K added.
Based on aggregated 13F filings for Q4 2025.